US2016262633A1PendingUtilityA1

Device and method for screening congenital heart disease

Assignee: LOS ANGELES BIOMEDICAL RES INST AT HARBOR-UCLA MEDICAL CENTERPriority: Jul 6, 2006Filed: May 24, 2016Published: Sep 15, 2016
Est. expiryJul 6, 2026(expired)· nominal 20-yr term from priority
Inventors:Ruey-Kang Chang
A61B 5/14551A61B 5/0205A61B 2562/222A61B 2560/0412A61B 7/026A61B 5/6823A61B 5/7282A61B 5/6841A61B 5/742A61B 5/6829A61B 7/02A61B 2503/045G16H 15/00G16H 50/30A61B 5/282
55
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Described are congenital heart disease monitors. The monitors can include one or more processing units configured to receive multiple signals, wherein the multiple signals can include a first signal from a pulse oximetry sensor; and at least one additional signal from a sensor at another body region for screening for congenital heart disease. In embodiments, the first signal and the at least one additional signal can be used to detect a presence of congenital heart disease.

Claims

exact text as granted — not AI-modified
I claim: 
     
         1 . A congenital heart disease monitor comprising:
 one or more processing units configured to receive multiple signals, wherein the multiple signals include:
 a first signal from a pulse oximetry sensor; and 
 at least one additional signal from a sensor at another body region for screening for congenital heart disease; 
   wherein the first signal and the at least one additional signal are used to detect a presence of congenital heart disease.   
     
     
         2 . The congenital heart disease monitor of  claim 1 , wherein the pulse oximetry sensor is located on a toe. 
     
     
         3 . The congenital heart disease monitor of  claim 1 , wherein another body region deemed suitable for screening for congenital heart disease is on a patient's frontal plane. 
     
     
         4 . The congenital heart disease monitor of  claim 1 , wherein the pulse oximetry sensor is located on a limb. 
     
     
         5 . The congenital heart disease monitor of  claim 1 , wherein the pulse oximetry sensor is an LNOP sensor. 
     
     
         6 . The congenital heart disease monitor of  claim 1 , wherein the pulse oximetry sensor is included in a probe. 
     
     
         7 . The congenital heart disease monitor of  claim 1 , wherein the probe is configured to hold the pulse oximetry sensor against a body region. 
     
     
         8 . The congenital heart disease monitor of  claim 1 , wherein the first signal and the at least one additional signal are screened for detected oxygen saturation. 
     
     
         9 . The congenital heart disease monitor of  claim 1 , wherein the at least one additional signal is from a pulse oximetry sensor, an ECG, or a phonocardiogram. 
     
     
         10 . The congenital heart disease monitor of  claim 1 , wherein congenital heart disease exists when an oxygen saturation level is less than 95%. 
     
     
         11 . A method of detecting congenital heart disease using a congenital heart disease monitor, the method comprising:
 collecting multiple signals provided by the congenital heart disease monitor, wherein the multiple signals include:
 a first signal from a pulse oximetry sensor; and 
 at least one additional signal from a sensor at another body region for screening for congenital heart disease; 
   using the collected signals to determine when a newborn has congenital heart disease when a reading of an oxygen saturation level less than 95%.   
     
     
         12 . The method of  claim 11 , wherein another body region suitable for screening for congenital heart disease is on a frontal plane of the newborn. 
     
     
         13 . The method of  claim 11 , wherein the pulse oximetry sensor is an LNOP sensor. 
     
     
         14 . The method of  claim 11 , wherein the pulse oximetry sensor is located on a toe. 
     
     
         15 . The method of  claim 11 , wherein the comparing is performed using an algorithm on one or more processing units configured to receive the multiple signals. 
     
     
         16 . The method of  claim 11 , wherein the at least one additional signal is from another pulse oximetry sensor. 
     
     
         17 . The method of  claim 11 , wherein the first signal and the at least one additional signal are screened for detected oxygen saturation. 
     
     
         18 . The method of  claim 11 , wherein the at least one additional signal is from a pulse oximetry sensor, an ECG, or a phonocardiogram. 
     
     
         19 . The congenital heart disease monitor of  claim 1 , wherein the congenital heart disease monitor includes a display. 
     
     
         20 . A congenital heart disease monitor comprising:
 one or more processing units configured to receive multiple signals, wherein the multiple signals include:
 a first signal from a pulse oximetry sensor located on a toe of a newborn; and 
 at least one additional signal from a sensor at another body region; 
   wherein the first signal and the at least one additional signal are used to determine if an oxygen saturation level is less than 95% of normal oxygen saturation levels.

Join the waitlist — get patent alerts

Track US2016262633A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.